Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 2.07 Delayed Data As of 10:04am ET |  -0.03 / -1.43%Today’s Change | 1.40 Today|||52-Week Range 5.44 | -28.12% Year-to-Date |
| 5 Biotech Stocks to Watch as Interest in NASH Increases Sep 22 / Zacks.com - Paid Partner Content | Here's Why Conatus Pharmaceuticals (CNAT) Stock Is Soaring Today Sep 20 / TheStreet.com - Paid Partner Content |
| Biotech ETFs in Focus on Tobira Therapeutics' Massive Gain Sep 21 / Zacks.com - Paid Partner Content | These Biotech Names Are on My Radar Sep 20 / TheStreet.com - Paid Partner Content |
| Previous close | 2.10 |
| Today’s open | 2.13 |
| Day’s range | 2.06 - 2.13 |
| Volume | 84,330 |
| Average volume (3 months) | 338,299 |
| Market cap | $46.4M |
| Dividend yield | -- |
| Earnings growth (last year) | +9.72% |
| Earnings growth (this year) | -3.33% |
| Earnings growth (next 5 years) | +74.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.21 |
| Today’s change | Today’s % change | |
|---|---|---|
| AMPEAmpio Pharmaceutical... | +0.00 | +0.45% |
| OREXOrexigen Therapeutic... | +0.05 | +1.54% |
| PRANPrana Biotechnology ... | -0.02 | -0.40% |
| MTEXMannatech Inc | -0.22 | -1.23% |
| Next reporting date | November 9, 2016 |
| EPS forecast (this quarter) | -$0.34 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$24.1M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Steven J. Mento |
Chief Financial Officer, Secretary & SVP-Finance Charles J. Cashion |
Corporate headquarters San Diego, California |
